Metastatic Urothelial Carcinoma: Have We Take the Road to the Personalized Medicine?

Cells. 2022 May 11;11(10):1614. doi: 10.3390/cells11101614.

Abstract

Urothelial cancer is a lethal malignancy characterized by a wide diffusion in Western countries due to a larger exposure to known risk factors, such as aromatic amines, tobacco smoke and benzene [...].

Keywords: FGFR inhibitors; enfortumab vedotin; immunotherapy; urothelial cancer.

Publication types

  • Editorial

MeSH terms

  • Carcinoma, Transitional Cell* / chemically induced
  • Carcinoma, Transitional Cell* / complications
  • Precision Medicine
  • Smoke / adverse effects
  • Urinary Bladder Neoplasms* / etiology
  • Urinary Bladder Neoplasms* / therapy

Substances

  • Smoke

Grants and funding

This research received no external funding.